The dsRNA binding site of human toll-like receptor 3

被引:171
作者
Bell, Jessica K.
Askins, Janine
Hall, Pamela R.
Davies, David R.
Segal, David M.
机构
[1] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
关键词
double-stranded RNA; innate immunity; leucine-rich repeat;
D O I
10.1073/pnas.0603245103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pathogen recognition by Toll-like receptors (TLRs) initiates innate immune responses that are essential for inhibiting pathogen dissemination and for the development of acquired immunity. The TLRs recognize pathogens with their N-terminal ectodomains (ECD), but the molecular basis for this recognition is not known. Recently we reported the x-ray structure for unliganded TLR3-ECD; however, it has proven difficult to obtain a crystal structure of TLR3 with its ligand, dsRNA. We have now located the TLR3 ligand binding site by mutational analysis. More than 50 single-residue mutations have been generated throughout the TLR3-ECD, but only two, H539E and N541A, resulted in the loss of TLR3 activation and ligand binding functions. These mutations locate the dsRNA binding site on the glycan-free, lateral surface of TLR3 toward the C terminus and suggest a model for dsRNA binding and TLR3 activation.
引用
收藏
页码:8792 / 8797
页数:6
相关论文
共 50 条
  • [41] Toll-like receptor system and endometriosis
    Khan, Khaleque Newaz
    Kitajima, Michio
    Fujishita, Akira
    Nakashima, Masahiro
    Masuzaki, Hideaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (08) : 1281 - 1292
  • [42] Toll-like receptor agonists as cancer vaccine adjuvants
    Jeon, Donghwan
    Hill, Ethan
    Mcneel, Douglas G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [43] Toll-like receptor 4 and atherogenesis
    Kiechl, S
    Wiedermann, CJ
    Willeit, J
    ANNALS OF MEDICINE, 2003, 35 (03) : 164 - 171
  • [44] Toll-like receptor downstream signaling
    Kawai, T
    Akira, S
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (01) : 12 - 19
  • [45] Modulation of toll-like receptor signaling by antimicrobial peptides
    Lee, Ernest Y.
    Lee, Michelle W.
    Wong, Gerard C. L.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2019, 88 : 173 - 184
  • [46] Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension
    Farkas, Daniela
    Thompson, A. A. Roger
    Bhagwani, Aneel R.
    Hultman, Schuyler
    Ji, Hyun
    Kotha, Naveen
    Farr, Grant
    Arnold, Nadine D.
    Braithwaite, Adam
    Casbolt, Helen
    Cole, Jennifer E.
    Sabroe, Ian
    Monaco, Claudia
    Cool, Carlyne D.
    Goncharova, Elena A.
    Lawrie, Allan
    Farkas, Laszlo
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (02) : 199 - 210
  • [47] Toll-Like Receptor 3 Influences Glucose Homeostasis and β-Cell Insulin Secretion
    Strodthoff, Daniela
    Ma, Zuheng
    Wirstrom, Tina
    Strawbridge, Rona J.
    Ketelhuth, Daniel F. J.
    Engel, David
    Clarke, Robert
    Falkmer, Sture
    Hamsten, Anders
    Hansson, Goran K.
    Bjorklund, Anneli
    Lundberg, Anna M.
    DIABETES, 2015, 64 (10) : 3425 - 3438
  • [48] Toll-like receptor signaling in teleosts
    Su, Jianguo
    SCIENCE CHINA-LIFE SCIENCES, 2025,
  • [49] Toll-like receptor responses in tuatara
    La Flamme, Anne Camille
    de Thierry, Danielle
    O'Neill, Shay
    Miller, Hilary
    NEW ZEALAND JOURNAL OF ZOOLOGY, 2010, 37 (03) : 235 - 242
  • [50] Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance
    Muresan, Ximena Maria
    Bouchal, Jan
    Culig, Zoran
    Soucek, Karel
    CANCERS, 2020, 12 (11) : 1 - 13